Serum level of adiponectin and its association with insulin sensitivity in overweight diabetic and non-diabetic Iranian men

Iranian Journal of Public Health

Volumn 37, Issue 2, 2008, Pages 88-92

  Giahi, L ^a   Djazayery, A ^a   Rahimy, A ^a   Rahmany, M ^b   Larijani, B ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b University of Medical Sciences   (Iran)

Author keywords

Adiponectin; Diabetes; Insulin sensitivity; Iran; Over weight

Indexed keywords

EID: 51749117381     PISSN: 22516085     EISSN: 22516093     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Maeda K, Okubo K, Shimomura I (1996). cDNA cloning and expression of a novel adipose specific collagen-like factor, APM 1 (Adipose most gene transcript 1). Biochem Biophys Res Commun, 221:286-9.
2. Scherer PE, Williams S, Fogliano M, Baldini G, Lodish HF (1995). A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem, 270: 26746-749.
3. Trujillo ME, Scherer PE (2005). Adiponectin-journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. J Intern Med, 257:167-75.
4. Koerner J, Kratzsch W (2005). Adipocytokines: leptin-the classical, resistin-the controversical, adiponectin- the promising, and more to come. Best Pract & Res Clin Endocrinol Metab, 19(4):525-46 A.
5. Hu E, Liang P, Spiegelman BM (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem, 271:10697-703.
6. Statnick MA, Beavers LS, Conner LJ, Corominola H, Johnson D, Hammond CD, et al. (2000). Decreased expression of apM1 in omental and subcutaneous adipose tissue of humans with type 2 diabetes. Int J Exp Diabetes Res, 1:81-8.
7. Haluzik M, Parizkova J, Haluzik MM (2004). Adiponectin and its role in the obesity induced insulin resistance and related complications. Physiol Res, 53:123-29.
8. Matsubara M, Katyose S, Maruoka S (2003). Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios. Eur J Endocrinol, 148:343-50.
9. Nadler ST, Stoehr JP, Schueller KL, Tanmoto G, Yandell BS, Attie AD (2001). The expression of adipogenic genes is decreased in obesity and diabetes mellitus. Proc Natl Acad Sci USA, 97:11371-376.
10. Hrebicek J, Janout V, Malincikova J, Horakova D, Cizek L (2002). Detection of insulin resistance by simple quantitative insulin sensitivity check index QUICKI for epidemiological assessment and prevention. J Clin Endocrinol Metab, 87(1):144-47.
11. Lindsay RS, Funahashi T, Hanson RL, Matsuzawa Y, Tanaka S, Tataranni PA, Knowler WC, Krakoff J (2002). Adiponectin and development of type 2 diabetes in the Pima Indian population. Lancet, 360(9326):57-8.
12. Snehalatha C, Mukesh B, Simon M, Viswanathan V (2003). Plasma Adiponectin Is an Independent Predictor of Type 2 Diabetes in Asian Indians. Diabetes Care, 26:3226-29.
13. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y (2001). Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab, 86(5): 1930-35.
14. Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K, et al. (2001). The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nature Med, 7:941-46.
15. Matsubara M, Maruoka S, Katayose S (2002). Inverse relationship between plasma adiponectin and leptin concentrations in normal-weight and obese women. Eur J Endocrinol, 147(2):173-80.
16. Yamamoto Y, Hirose H, Satto I, Tomita M, (2002). Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum high-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population. Clinical Science, 103:137-42.
17. Arita Y, Kihara S, Ouchi N (1999). Paradoxical decrease of obtain a better understanding of adiponectin's role in the adipose-specific protein, adiponectin in obesity. Biochem Biophys Res Commun, 257:79-83.
18. Ma K, Cabrero A, Saha PK, Kojima H, Li L, Chang BH, et al. (2002). Increased β-oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem, 277:34658-661.
19. Kubota N, Terauchi Y, Yamauchi T, Kubota T (2002). Disruption of adiponectin causes insulin resistance and neointimal formation. J Biol Chem, 277(29):25863-866.
20. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE (2001). The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nature Med, 7:947-53.
21. Vettor R, MILAN G, Rossato M, Federspil G (2005). Review article: adipocytokines and insulin resistance. Aliment Pharmacol Ther, 22(2):3-10.
22. Spranger J, Kroke A, Mohlig M, Bergmann MM, Ristow M, Boeing H, et al. (2003). Adiponectin and protection against type 2 diabetes mellitus. Lancet, 361(9353):226-28.
23. Nedvidkova A, Smitka k, Kopsky V, Hainer V (2005). Adiponectin, an adipocyte-derived protein. Physiological research, 54(2):133-40.
24. Tschritter O, Fritche A, Thamer C, (2003). Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism. Diabetes, 52:239-43.